Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangjun Zhang

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC-1α-mediated Transcriptional CoactivationChen Duan, Bo Li, Haoran Liu, et al.
Frontiers in Oncology|October 9, 2023
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumorsChen Duan, Yangjun Zhang, Lu Li, et al.
Proteomics|July 30, 2005
Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome ProjectXiaohai Li, Yan Gong, Ying Wang, et al.
Frontiers in Molecular Biosciences|November 21, 2022
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma <i>via</i> promoting proliferation and epithelial-mesenchymal transitionGuoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics|January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: ErratumLibin Yan, Beichen Ding, Haoran Liu, et al.
Frontiers in Molecular Biosciences|June 14, 2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma <i>via</i> Promoting Proliferation and Epithelial-Mesenchymal TransitionGuoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics|November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinomaLibin Yan, Beichen Ding, Haoran Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 18, 2025
Integrative Omics Reveals Glutamine Catabolism-Driven Apoptotic Suppression in Monocytes upon Mechanical UnloadingYi Ding, Fan Tong, Mingqiu Liu, et al.
Genes & Diseases|December 5, 2024
The AKT1-mTOR signaling cascade is crucial for SOX3 to promote hepatocarcinogenesisYang Liu, Feifei Song, Xianhuang Zeng, et al.
Cancer Communications (London, England)|February 16, 2021
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinomaKe Chen, Jin Zeng, Yi Sun, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC-1α-mediated Transcriptional CoactivationChen Duan, Bo Li, Haoran Liu, et al.
Frontiers in Oncology|October 9, 2023
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumorsChen Duan, Yangjun Zhang, Lu Li, et al.
Proteomics|July 30, 2005
Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome ProjectXiaohai Li, Yan Gong, Ying Wang, et al.
Frontiers in Molecular Biosciences|November 21, 2022
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma <i>via</i> promoting proliferation and epithelial-mesenchymal transitionGuoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics|January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: ErratumLibin Yan, Beichen Ding, Haoran Liu, et al.
Frontiers in Molecular Biosciences|June 14, 2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma <i>via</i> Promoting Proliferation and Epithelial-Mesenchymal TransitionGuoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics|November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinomaLibin Yan, Beichen Ding, Haoran Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 18, 2025
Integrative Omics Reveals Glutamine Catabolism-Driven Apoptotic Suppression in Monocytes upon Mechanical UnloadingYi Ding, Fan Tong, Mingqiu Liu, et al.
Genes & Diseases|December 5, 2024
The AKT1-mTOR signaling cascade is crucial for SOX3 to promote hepatocarcinogenesisYang Liu, Feifei Song, Xianhuang Zeng, et al.
Cancer Communications (London, England)|February 16, 2021
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinomaKe Chen, Jin Zeng, Yi Sun, et al.
Pageof 15